SCHEMBL1009271

SCHEMBL1009271

COc1ccc(CN2C=CN(C)C2)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALOX15 P16050 1/20 0.47
CMA1 P23946 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
HRH3 Q9Y5N1 1/20 0.44
CHKA P35790 1/20 0.43
PTGIR P43119 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2196195 0.98 SIGMAR1 (0.46) SIGMAR1ALDH1A1MAPTKDM4EALOX15
SCHEMBL15429645 0.89 CMA1 (0.58) SIGMAR1ALDH1A1MAPTKDM4EALOX15
Hydrochloric Acid SCHEMBL2530335 0.87 CMA1 (0.56) SIGMAR1ALDH1A1MAPTKDM4EALOX15
SCHEMBL15803245 0.87 HRH3 (0.34) ALDH1A1MAPTHRH3CHKALMNA
SCHEMBL15803247 0.82 HRH3 (0.43) HRH3CHKA
SCHEMBL12220197 0.81 CMA1 (0.50) SIGMAR1ALDH1A1MAPTKDM4EALOX15
Bromide SCHEMBL9661608 0.81 SIGMAR1 (0.50) SIGMAR1ALOX15GSK3AGSK3BHRH3
SCHEMBL1011075 0.81 LPO (0.54) SIGMAR1ALDH1A1MAPTKDM4ECMA1
SCHEMBL31177907 0.81 LPO (0.54) SIGMAR1ALDH1A1MAPTKDM4ECMA1
SCHEMBL28786436 0.81 SMN1; SMN2 (0.33) SIGMAR1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104781251-B Can as kinase modulator through the substituted pyridinyl compounds of bicyclic heterocycle 百时美施贵宝公司 2016-12-14 CN disclosed
CN-104781251-A Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators BRISTOL MYERS SQUIBB CO 2015-07-15 CN disclosed
EP-2268652-B1 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-12-19 EP disclosed
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed